Cohu (COHU) sr VP Bohrson sells $38000 in stock By Investing.com

Cohu disclosed a $30 million follow-on order win for its Eclipse platform, with additional multi-unit demand from a U.S. semiconductor manufacturer for AI datacenter processor development. Stifel raised its price target to $34, Needham lifted theirs to $33, and Evercore ISI initiated coverage at $35, reflecting improving sentiment around Cohu’s position in AI chip testing. Separately, Senior VP Christopher Bohrson sold 1,000 RSUs at $38.00, totaling $38,000, under a pre-arranged 10b5-1 plan.

Analysis

The incremental signal here is not the insider sale itself — the 10b5-1 context makes it low-information — but the clustering of order wins and target raises around a product line that is likely becoming the firm’s de facto AI/HPC call option. When a mid-cap test-equipment vendor starts stacking follow-on orders from both hyperscaler-adjacent and domestic semiconductor customers, it usually means qualification risk has declined enough that buyers are moving from evaluation to deployment, which is the phase where revenue visibility can inflect faster than headline bookings suggest.

Second-order, the competitive read-through is more important than the company-specific one. If Eclipse is gaining traction in advanced processor validation, smaller probe/test rivals with narrower AI exposure may see design-win pressure, while larger incumbents could be forced to defend share with price or bundled service agreements. The near-term opportunity is likely in mix, not just units: once platforms move into production ramp, utilization and service attach rates can improve margins even if gross margin remains noisy from inventory digestion.

The main risk is that analysts are extrapolating a cyclical recovery and an AI testing upgrade cycle at the same time, which can overstate durability. The setup is strongest over a 3-9 month horizon if follow-on orders convert into repeatable multi-quarter demand; it breaks if semiconductor capex pauses, if the AI test ramp proves front-loaded, or if gross margins fail to recover after the one-time charge fades. Insiders selling into strength is not bearish by itself, but it does argue for respecting valuation if the stock re-rates ahead of actual margin inflection.

Contrarian view: the market may be underpricing how much of the upside is already in the stock after multiple analyst target resets, especially if expectations have moved faster than earnings revisions. The better trade is not a blind outright long, but a structure that captures a continuation in order momentum while limiting downside if the “AI testing winner” narrative cools.

Key Decisions for Investors

• Go long COHU on pullbacks over the next 1-2 weeks, using a 3-6 month horizon; target a re-rating toward the upper end of analyst targets if follow-on orders continue, but keep a tight risk limit if the stock fails to hold recent support after the next earnings-related data point.
• Preferred expression: buy COHU calls or call spreads 2-4 months out to capture the next order backlog update; upside is tied to multiple expansion, while premium paid caps risk if semiconductor capex sentiment softens.
• Pair trade: long COHU / short a broader semiconductor equipment basket over 1-3 months if you want targeted exposure to AI test-content acceleration without betting on the full cycle; this works best if COHU’s order book proves more resilient than the group.
• If COHU rallies into the next analyst note or order headline, consider trimming 25-50% into strength; the market is likely to over-discount the narrative before margins confirm.
• Set a downside alert around any sign of delayed delivery or reduced follow-on order cadence; that would be the cleanest signal to exit, because the thesis depends on conversion from announcement-driven optimism to recurring revenue within the next 2-3 quarters.